RecallDepth
Class II Terminated

Desloratadine Tablets USP 5mg a) 100 count (NDC 68180-153-01) and b) 500 count (NDC 68180-153-02) bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202.

Company
Lupin Pharmaceuticals Inc.
Recall Initiated
December 20, 2023
Posted
January 17, 2024
Recall Number
D-0221-2024
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
100=29,184 bottles; 500=2922 bottles
Firm Location
Baltimore, MD, United States

Reason for Recall

CGMP Deviations: N-Nitroso Desloratadine impurity result exceeded the acceptable intake limit.

Distribution

Product was distributed nationwide.

Lot / Code Info

Lot # G201822, exp. date Jan 2024, 100 count G201823, exp. date Jan 2024, 100 count G201824, exp. date Jan 2024, 500 count

More recalls by Lupin Pharmaceuticals Inc.

View all recalls by this company →

Other recent Class II Drug recalls